Back to search

University of Ioannina

Συσχέτιση ποσότητας αδιπονεκτίνης στο πλάσμα εγκύου γυναίκας και κινδύνου εμφάνισης διαβήτη κύησης

Abstract

dc:description

Introduction: Gestational Diabetes Mellitus (GDM) and maternal obesity represent major challenges in modern Obstetrics, significantly influencing the overall cardiometabolic health of both mother and neonate (108). Adiponectin, an adipokine with established insulin-sensitizing and anti-inflammatory properties, circulates in distinct polymeric isoforms (48). Current literature suggests that the High Molecular Weight (HMW) isoform acts as the primary biological mediator; however, its dynamics within the maternal-fetal axis remain under investigation (107).Aim of the Study: The present thesis explored the polymeric adiponectin profile across the maternal–placental–fetal axis. The primary objectives included evaluating the predictive value of these isoforms in GDM diagnosis, investigating their potential in predicting therapeutic failure of dietary interventions (requirement for insulin therapy), and contributing to the clarification of intrauterine metabolic programming mechanisms.Methodology: A prospective study was conducted on 130 pregnant women during a glucose tolerance test (75g OGTT) at 24-28 weeks of gestation. Total adiponectin and its isoforms (HMW, MMW, LMW) were determined in maternal serum at sequential time points (0, 60, 120, and 180 minutes). Concurrently, isoform levels were measured in umbilical cord blood (cb). Data were correlated with pre-pregnancy Body Mass Index (BMI), glycemic profile, and neonatal anthropometric parameters across the entire study population.Results: Statistical analysis identified maternal HMW adiponectin (mHMW-Ad) as a particularly reliable biomarker for GDM diagnosis, frequently demonstrating greater predictive accuracy compared to total adiponectin (107). Its significance persisted after adjusting for pre-pregnancy BMI, while the 180-minute kinetics provided evidence of limited metabolic flexibility in women with GDM. Low mHMW-Ad levels appeared to be associated with an increased probability of requiring insulin therapy (108). In the fetal compartment, a trend toward metabolic autonomy was observed: in an environment of maternal insulin resistance, the fetus may exhibit a compensatory increase in fetal HMW adiponectin (71). Furthermore, the MMW isoform may function as a "metabolic brake," showing a negative correlation with birth weight (82), with variations that possibly suggest fetal sexual dimorphism.Conclusions: The qualitative composition of the adiponectin profile appears to provide more significant information than simple quantitative measurement in pregnancy management (107). The emergence of a fetal compensatory response supports Barker’s theory and the Pedersen hypothesis (108, 123). The integration of isoform analysis into clinical practice could contribute to the rationalization of personalized care, while the identification of women with reduced mHMW-Ad highlights the utility of systematic monitoring aimed at early intervention against metabolic syndrome.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Salvanos, Georgios
  • Σαλβάνος, Γεώργιος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/63075

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Salvanos, Georgios; Σαλβάνος, Γεώργιος. Συσχέτιση ποσότητας αδιπονεκτίνης στο πλάσμα εγκύου γυναίκας και κινδύνου εμφάνισης διαβήτη κύησης. University of Ioannina, 2026. http://hdl.handle.net/10442/hedi/63075